SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filing Details

Document Details

Form
Filing Date
Feb 28, 2024
Document Date
Dec 31, 2023
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC